Anti-human CD107a (LAMP-1) Antibody Review

We are interested in enhancing the killing capacity of HIV-specific CD8 T cells by activating them via TCR specific MHC-peptide ligands, and co-stimulatory molecules. We use purified CD8 T cells from naive donors with HLA types, and stimulate them in vitro to then look at their degranulation and cytokine profile. The data shown here represents results from a positive control, where CD8 T cells were activated with PMA and ionomycin and then stained different cytokine production.